We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$6.17B
AUM Growth
+$971M
Cap. Flow
+$684M
Cap. Flow %
11.08%
Top 10 Hldgs %
26.22%
Holding
1,261
New
68
Increased
1,018
Reduced
143
Closed
27
Avg Time Held
8 quarters
Top 10 Avg Time Held
8.1 quarters
Top 20 Avg Time Held
6.1 quarters

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$39.5M
2
AAPL icon
Apple
AAPL
+$38.5M
3
AMZN icon
Amazon
AMZN
+$20M
4
TSLA icon
Tesla
TSLA
+$12.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$11.6M

Sector Composition

Rank Sector Weight
1 Technology 27.46%
2 Healthcare 14.84%
3 Financials 12.1%
4 Consumer Discretionary 10.98%
5 Industrials 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MAXR
1101
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$221K ﹤0.01%
+4,271
New +$117K
2022 Q4
0 quarters
BIPC icon
1102
Brookfield Infrastructure
BIPC
$4.57B
$220K ﹤0.01%
5,643
+115
+2% +$4.88K
2022 Q1
3 quarters
RMBS icon
1103
Rambus
RMBS
$11.1B
$219K ﹤0.01%
+6,121
New +$207K
2022 Q4
0 quarters
RXDX
1104
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$219K ﹤0.01%
+1,991
New +$129K
2022 Q4
0 quarters
FRPT icon
1105
Freshpet
FRPT
$3.13B
$219K ﹤0.01%
+4,141
New +$246K
2022 Q4
0 quarters
FUL icon
1106
H.B. Fuller
FUL
$2.67B
$218K ﹤0.01%
+3,045
New +$220K
2022 Q4
0 quarters
CG icon
1107
Carlyle Group
CG
$13.6B
$218K ﹤0.01%
+7,296
New +$208K
2022 Q4
0 quarters
PATH icon
1108
UiPath
PATH
$6.84B
$217K ﹤0.01%
17,047
+6,226
+58% +$76.9K
2022 Q2
2 quarters
ST icon
1109
Sensata Technologies
ST
$6.14B
$216K ﹤0.01%
+5,359
New +$223K
2022 Q4
0 quarters
CYTK icon
1110
Cytokinetics
CYTK
$8.75B
$215K ﹤0.01%
4,699
+73
+2% +$3.14K
2022 Q3
1 quarter
VRT icon
1111
Vertiv
VRT
$92.6B
$215K ﹤0.01%
15,750
+5,737
+57% +$76.5K
2020 Q2
10 quarters
BL icon
1112
BlackLine
BL
$1.71B
$213K ﹤0.01%
+3,163
New +$196K
2022 Q4
0 quarters
MDGL icon
1113
Madrigal Pharmaceuticals
MDGL
$10.8B
$212K ﹤0.01%
+729
New +$71.3K
2022 Q4
0 quarters
Z icon
1114
Zillow
Z
$6.32B
$211K ﹤0.01%
+6,537
New +$217K
2022 Q4
0 quarters
BXMT icon
1115
Blackstone Mortgage Trust
BXMT
$1.82B
$207K ﹤0.01%
9,780
+207
+2% +$4.9K
2021 Q2
6 quarters
MRVI icon
1116
Maravai LifeSciences
MRVI
$1.04B
$207K ﹤0.01%
14,463
+1,435
+11% +$22.6K
2021 Q2
6 quarters
PTEN icon
1117
Patterson-UTI
PTEN
$4.35B
$207K ﹤0.01%
12,280
+179
+1% +$2.95K
2022 Q2
2 quarters
WFRD icon
1118
Weatherford International
WFRD
$5.54B
$206K ﹤0.01%
+4,040
New +$167K
2022 Q4
0 quarters
UCB icon
1119
United Community Banks
UCB
$4.06B
$206K ﹤0.01%
+6,086
New +$221K
2022 Q4
0 quarters
AGNC icon
1120
AGNC Investment
AGNC
$10.3B
$203K ﹤0.01%
+19,605
New +$179K
2022 Q4
0 quarters
DV icon
1121
DoubleVerify
DV
$2.11B
$202K ﹤0.01%
+9,181
New +$239K
2022 Q4
0 quarters
BE icon
1122
Bloom Energy
BE
$76.6B
$197K ﹤0.01%
+10,296
New +$202K
2022 Q4
0 quarters
SHC icon
1123
Sotera Health
SHC
$5.15B
$197K ﹤0.01%
23,626
+2,108
+10% +$15.7K
2021 Q2
6 quarters
APLE icon
1124
Apple Hospitality REIT
APLE
$3.86B
$195K ﹤0.01%
12,368
+218
+2% +$3.52K
2021 Q2
6 quarters
FOLD icon
1125
DELISTED
Amicus Therapeutics
FOLD
$193K ﹤0.01%
15,771
+263
+2% +$2.96K
2021 Q2
6 quarters

Similar funds

Xponance's Q4 2022 Portfolio in Review

As of Q4 2022, Xponance held 1,261 positions worth $6.17B, up 19% from $5.2B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Xponance deployed $684M of net new capital in Q4 2022, opening 68 new positions and adding to 1,018 existing holdings. Its largest new stake was Atlassian: 19,409 shares worth $2.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Everest Group, an estimated $1.58M trimmed.

  • Xponance's largest Q4 2022 buy was Atlassian: 19,409 shares worth $2.5M.
  • Xponance added most to Microsoft in Q4 2022, an estimated $39.5M increase.
  • Xponance's biggest Q4 2022 reduction was Everest Group, cutting an estimated $1.58M.
  • Xponance fully exited Twitter, Inc. in Q4 2022, selling an estimated $6.1M.
  • Xponance's ten largest holdings make up 26% of its $6.17B portfolio in Q4 2022.
  • Xponance opened 68 new positions and closed 27 in Q4 2022.
  • Xponance's portfolio value rose 19% quarter-over-quarter to $6.17B.

Based on Xponance's 13F filing for Q4 2022, filed 24 Jan 2023.